Stock listing
Theraclion Sa
Selected listing: ALTHE · EURONEXT · EUR · FR
Theraclion Sa (Euronext:ALTHE), Health Technology. Latest release Sep 16, 2026: 2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development.

- Ticker
- Euronext:ALTHE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Euronext
- Currency
- EUR
About Theraclion Sa
Theraclion SA is a public company listed on the French market under the ticker ALTHE. Theraclion specializes in innovative medical technologies, focusing on ultrasound-based solutions for the treatment of various conditions.
Latest news from Theraclion Sa
2026 Half-Year Results: Theraclion Prepares for a New Stage in Its Development
September 16, 2026
Theraclion Initiates Its Commercial Momentum in the First Half of 2026
July 23, 2026
Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL
July 15, 2026
Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors
July 9, 2026
Theraclion Announces the Evolution of Its Board of Directors
June 18, 2026
Research Theraclion Sa
Alternate listings
941:GETTEX
DE · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
941:FWB
DE · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
A112C8:LSX
DE · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
A112C8:LS
DE · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
941:SWB
DE · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
ALTHEP:TURQUOISE
GB · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
941:MUN
DE · EUR
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.
TCLIF:OTC
US · USD
Alternate listing for Theraclion Sa; the primary context on this page is ALTHE:EURONEXT.